Cargando…

Novel approaches to render stable producer cell lines viable for the commercial manufacturing of rAAV-based gene therapy vectors

Detalles Bibliográficos
Autores principales:	Emmerling, Verena V, Holzmann, Karlheinz, Lanz, Karin, Kochanek, Stefan, Hörer, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980429/ http://dx.doi.org/10.1186/1753-6561-7-S6-P12

Ejemplares similares

rAAV Manufacturing: The Challenges of Soft Sensing during Upstream Processing
por: Iglesias, Cristovão Freitas, et al.
Publicado: (2023)

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method
por: Rao, Renuka, et al.
Publicado: (2022)

Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system
por: Galibert, Lionel, et al.
Publicado: (2018)

rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ
por: Madry, Henning, et al.
Publicado: (2012)

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013)

Proteomics Analysis of Co-Purifying Cellular Proteins Associated with rAAV Vectors
por: Dong, Biao, et al.
Publicado: (2014)

Molecular design for recombinant adeno-associated virus (rAAV) vector production
por: Aponte-Ubillus, Juan Jose, et al.
Publicado: (2017)

An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons
por: Tkatch, Tatiana, et al.
Publicado: (2022)

The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector
por: Li, Rilun, et al.
Publicado: (2013)

Gene Delivery to Adipose Tissue Using Transcriptionally Targeted rAAV8 Vectors
por: Uhrig-Schmidt, Silke, et al.
Publicado: (2014)

Identification of Novel Retinal Pericyte-Targeting rAAV Vectors Through Directed Evolution
por: Patel, Dwani D., et al.
Publicado: (2022)

Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum
por: Osting, Sue, et al.
Publicado: (2014)

Construction of an rAAV Producer Cell Line through Synthetic Biology
por: Lee, Zion, et al.
Publicado: (2022)

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
por: Ishii, Akiko, et al.
Publicado: (2020)

Long-term, efficient inhibition of microRNA function in mice using rAAV vectors
por: Xie, Jun, et al.
Publicado: (2012)

Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors
por: Ferrand, Maxime, et al.
Publicado: (2015)

Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
por: Zhan, Wei, et al.
Publicado: (2021)

Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation
por: Bieber, Scott, et al.
Publicado: (2013)

rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021)

VectorMOD: Method for Bottom-Up Proteomic Characterization of rAAV Capsid Post-Translational Modifications and Vector Impurities
por: Rumachik, Neil G., et al.
Publicado: (2021)

High-Level rAAV Vector Production by rAdV-Mediated Amplification of Small Amounts of Input Vector
por: Weger, Stefan
Publicado: (2022)

Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
por: Arnett, Andrea L. H., et al.
Publicado: (2011)

Controlled Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy
por: Alvarez-Rivera, Fernando, et al.
Publicado: (2020)

Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
por: Chu, Wing Sum, et al.
Publicado: (2021)

Monobac System–A Single Baculovirus for the Production of rAAV
por: Galibert, Lionel, et al.
Publicado: (2021)

Durability of transgene expression after rAAV gene therapy
por: Muhuri, Manish, et al.
Publicado: (2022)

Subcellular distribution of the rAAV genome depends on genome structure
por: Oh, Nuri, et al.
Publicado: (2023)

Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes
por: Zhang, Junping, et al.
Publicado: (2022)

Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy
por: Hagen, Sven, et al.
Publicado: (2014)

Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing
por: Lecomte, Emilie, et al.
Publicado: (2015)

Site-Specific Glycation and Chemo-enzymatic Antibody Sortagging for the Retargeting of rAAV6 to Inflamed Endothelium
por: Pearce, Hannah A., et al.
Publicado: (2019)

rAAV-compatible MiniPromoters for restricted expression in the brain and eye
por: de Leeuw, Charles N., et al.
Publicado: (2016)

Computational and molecular tools for scalable rAAV-mediated genome editing
por: Stoimenov, Ivaylo, et al.
Publicado: (2015)

Liver targeting with rAAV7: balancing tropism with immune profiles
por: Flotte, Terence R.
Publicado: (2021)

rAAV-PHP.B escapes the mouse eye and causes lethality whereas rAAV9 can transduce aniridic corneal limbal stem cells without lethality
por: Mirjalili Mohanna, Seyedeh Zeinab, et al.
Publicado: (2023)

Lack of Humoral Immune Response to the Tetracycline (Tet) Activator in Rats Injected Intracranially with Tet-off rAAV Vectors
por: Han, Ye, et al.
Publicado: (2010)

Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)
por: Demeules, Mélanie, et al.
Publicado: (2020)

Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno‐Associated Viral Vector rAAV9P1
por: Bauer, Amelie, et al.
Publicado: (2022)

Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays
por: Buck, Thilo M., et al.
Publicado: (2020)

Long term physiologic modification using rAAV in utero gene-therapy
por: Garrett, Deiadra J, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_u0ar1vhte3h8i0anbvr76sbm5k